Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study)

医学 无容量 肾细胞癌 内科学 肿瘤科 免疫疗法 癌症
作者
Sara Elena Rebuzzi,Alessio Signori,Giuseppe Luigi Banna,Marco Maruzzo,Ugo De Giorgi,Paolo Pedrazzoli,Andrea Sbrana,Paolo Andrea Zucali,Cristina Masini,Emanuele Naglieri,Giuseppe Procopio,Sara Merler,Laura Tomasello,Lucia Fratino,Cinzia Baldessari,Riccardo Ricotta,Stefano Panni,Veronica Mollica,Mariella Sorarú,Matteo Santoni,Alessio Cortellini,Veronica Prati,Héctor Soto Parrà,Marco Stellato,Francesco Atzori,Sandro Pignata,Carlo Messina,Marco Messina,Franco Morelli,Giuseppe Prati,Franco Nolè,Francesca Vignani,Alessia Cavo,Giandomenico Roviello,Francesco Pierantoni,Chiara Casadei,Melissa Bersanelli,Silvia Chiellino,Federico Paolieri,Matteo Perrino,Matteo Brunelli,Roberto Iacovelli,Camillo Porta,Sebastiano Buti,Giuseppe Fornarini
出处
期刊:Therapeutic Advances in Medical Oncology [SAGE Publishing]
卷期号:13: 175883592110196-175883592110196 被引量:49
标识
DOI:10.1177/17588359211019642
摘要

Background: Despite the survival advantage, not all metastatic renal cell carcinoma (mRCC) patients achieve a long-term benefit from immunotherapy. Moreover, the identification of prognostic biomarkers is still an unmet clinical need. Methods: This multicenter retrospective study investigated the prognostic role of peripheral-blood inflammatory indices and clinical factors to develop a novel prognostic score in mRCC patients receiving at least second-line nivolumab. The complete blood count before the first cycle of therapy was assessed by calculating neutrophil-to-lymphocyte ratio (NLR), derived NLR (dNLR), lymphocyte-to-monocyte ratio (LMR), platelet-to-lymphocyte ratio (PLR), systemic inflammation index (SII), and systemic inflammation response index (SIRI). Clinical factors included pre-treatment International Metastatic RCC Database Consortium (IMDC) score, line of therapy, and metastatic sites. Results: From October 2015 to November 2019, 571 mRCC patients received nivolumab as second- and further-line treatment in 69% and 31% of cases. In univariable and multivariable analyses all inflammatory indices, IMDC score, and bone metastases significantly correlated with overall survival (OS). The multivariable model with NLR, IMDC score, and bone metastases had the highest c-index (0.697) and was chosen for the developing of the score (Schneeweiss scoring system). After internal validation (bootstrap re-sampling), the final index (Meet-URO score) composed by NLR, IMDC score, and bone metastases had a c-index of 0.691. It identified five categories with distinctive OSs: group 1 (median OS – mOS = not reached), group 2 (mOS = 43.9 months), group 3 (mOS = 22.4 months), group 4 (mOS = 10.3 months), and group 5 (mOS = 3.2 months). Moreover, the Meet-URO score allowed for a fine risk-stratification across all three IMDC groups. Conclusion: The Meet-URO score allowed for the accurate stratification of pretreated mRCC patients receiving nivolumab and is easily applicable for clinical practice at no additional cost. Future steps include its external validation, the assessment of its predictivity, and its application to first-line combinations.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Nat完成签到,获得积分10
刚刚
phd_cheng完成签到,获得积分10
刚刚
叶祥完成签到,获得积分10
刚刚
小二郎的应助被月下思文采纳,获得10
1秒前
何皮皮发布了新的文献求助10
1秒前
emo小熊完成签到,获得积分10
1秒前
1秒前
2秒前
kk子的应助被逆天采纳,获得10
3秒前
小二郎的应助被Renee采纳,获得10
4秒前
4秒前
5秒前
上官若男的应助被will采纳,获得10
5秒前
NexusExplorer的应助被隐形的白凡采纳,获得10
6秒前
科研通AI6.3的应助被小陈采纳,获得10
6秒前
Clover04的应助被haha采纳,获得10
6秒前
初景的应助被haha采纳,获得20
6秒前
7秒前
Yanxin发布了新的文献求助30
7秒前
徐徐完成签到,获得积分10
8秒前
marisat完成签到,获得积分10
9秒前
Jack_Xue完成签到,获得积分10
9秒前
敏感初露发布了新的文献求助10
9秒前
10秒前
蒲公英完成签到,获得积分10
11秒前
11秒前
12秒前
受伤白安发布了新的文献求助10
12秒前
12秒前
科研通AI2S的应助被虞山小王子采纳,获得10
12秒前
12秒前
13秒前
13秒前
赵文福完成签到,获得积分10
13秒前
13秒前
Jack_Xue发布了新的文献求助10
14秒前
隐形曼青的应助被corleeang采纳,获得10
14秒前
14秒前
科研牛马完成签到,获得积分20
16秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8182238
求助须知:如何正确求助?哪些是违规求助? 9571879
关于积分的说明 21820474
捐赠科研通 7778782
什么是DOI,文献DOI怎么找? 3433645
关于科研通互助平台的介绍 2557824
邀请新用户注册赠送积分活动 2479666